Home » Topics » Regulatory

Regulatory
RSS

Pharmacia & Upjohn seeks approval for combination glaucoma therapy

Jan. 11, 2000

FDA approves liquid formulation of Celexa for treatment of depression

Jan. 10, 2000

The antiplatelet agent triflusal now shown to inhibit NF-kappaB activation

Jan. 10, 2000

Olanzapine and fluoxetine in combination useful for refractory depression

Jan. 10, 2000

Miltefosine tested as oral treatment for leishmaniasis

Jan. 4, 2000

CFC-free flunisolide to be developed by 3M/Forest partnership

Jan. 3, 2000

NDA filed for intranasal scopolamine during fourth quarter

Jan. 3, 2000

FDA approves Ligand's Targretin Capsules for treatment of CTCL

Dec. 30, 1999

AstraZeneca seeks approval of Atacand HCT in the U.S.

Dec. 30, 1999

Reboxetine + pindolol rapidly relieves symptoms of depression and other CNS disorders

Dec. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...